British Journal of Dermatology · 2003 · 79 citations · 17 references
MedicinePharmacologyPharmacotherapyImmunopharmacologyImmunotherapyRheumatologyChronic InflammationImmunostimulatory TherapyCentral Memory T CellsEffector Memory T CellsMemory Effector T CellsPlacebo-controlled Efficacy AssessmentPsoriasis ImmunopathologyPsoriasis TherapyPsoriatic DiseaseRemission Induction Therapy
BACKGROUND: Alefacept, human LFA-3/IgG1 fusion protein, is a novel biological agent currently being developed for the treatment of chronic plaque psoriasis. Alefacept selectively reduces the memory-effector T cells that have been implicated in the pathogenesis of the disease; as a result, alefacept is classified as a therapy that induces remission (so-called 'remittive' therapy). In a previously published randomized, placebo-controlled phase II study of intravenous alefacept in 229 patients with chronic plaque psoriasis, clinical improvement was observed during dosing as well as in the postdosing follow-up period. OBJECTIVES: To assess the remission period following alefacept therapy. METHODS: The time before re-treatment was required was measured in patients who were 'clear' or 'almost clear' of disease according to a physician global assessment at the end of the follow-up phase. RESULTS: In these patients, responses were sustained for a median of 10 months, and for up to 18 months. No patient reported disease rebound after cessation of alefacept. CONCLUSIONS: Alefacept is a biological agent for the treatment of chronic plaque psoriasis that provides disease-free intervals and time off drug therapy.
17
Martin E. Sanders, Malegapuru W. Makgoba, Susan O. Sharrow et al. · The Journal of Immunology · 1988 · 912 citations
Lisa M. Austin, Maki Ozawa, Toyoko Kikuchi et al. · Journal of Investigative Dermatology · 1999 · 483 citations · Full text
Medicine, Dermatology, Immunology +17
Cyclosporine for Plaque-Type Psoriasis
Charles N. Ellis, Mark S. Fradin, Joseph M. Messana et al. · New England Journal of Medicine · 1991 · 432 citations · Full text